Advertisement
Review| Volume 20, ISSUE 10, P754-760, December 2010

Download started.

Ok

Selenium status and cardiometabolic health: State of the evidence

  • S. Stranges
    Correspondence
    Corresponding author. Tel.: +44 2476151153; fax: +44 2476528375.
    Affiliations
    Health Sciences Research Institute, University of Warwick Medical School, Medical School Building, Room A105, Gibbet Hill Campus, Coventry CV4 7AL, UK
    Search for articles by this author
  • A. Navas-Acien
    Affiliations
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Search for articles by this author
  • M.P. Rayman
    Affiliations
    Nutritional Sciences Division, Faculty of Health and Medical Sciences, University of Surrey, UK
    Search for articles by this author
  • E. Guallar
    Affiliations
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid, Spain
    Search for articles by this author
Published:November 22, 2010DOI:https://doi.org/10.1016/j.numecd.2010.10.001

      Abstract

      Use of selenium enriched foods, supplements and fertilizers has increased markedly in recent years in the US and other Western countries because of the perception that the anti-oxidant properties of selenium could potentially reduce the risk of cancer and other chronic diseases. However, concern has been raised recently about possible adverse cardiometabolic effects of high selenium exposure, including an increased risk of diabetes and hyperlipidemia with high selenium intake. Hence, from a public health perspective, the relationship between selenium status and cardiometabolic health should be clarified in order to help guide consumers in their choices of nutritional supplements and enriched food products. Additional experimental evidence is needed to provide new insights into the role of selenium and of specific selenoproteins in human biology, especially to clarify the underlying mechanisms linking selenium to chronic disease endpoints. Further epidemiological studies and randomized clinical trials across populations with different selenium status should be conducted to determine the causal effect of selenium on cardiovascular disease and risk factors. Nevertheless, at the present time the widespread use of selenium supplements or other strategies that artificially increase selenium status above the level required for optimal selenoprotein activity is not justified and should not be encouraged.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Nutrition, Metabolism and Cardiovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Navas-Acien A.
        • Bleys J.
        • Guallar E.
        Selenium intake and cardiovascular risk – what is new?.
        Curr Opin Lipidol. 2008; 19: 43-49
        • Rayman M.P.
        Selenoproteins and human health: insights from epidemiological data.
        Biochim Biophys Acta. 2009; 1790: 1533-1540
        • Burk R.F.
        Selenium, an antioxidant nutrient.
        Nutr Clin Care. 2002; 5: 75-79
        • Papp L.V.
        • Lu J.
        • Holmgren A.
        • Khanna K.K.
        From selenium to selenoproteins: synthesis, identity, and their role in human health.
        Antioxid Redox Signal. 2007; 9: 775-806
        • Neve J.
        Selenium as a risk factor for cardiovascular diseases.
        J Cardiovasc Risk. 1996; 3: 42-44
        • Combs Jr., G.F.
        • Gray W.P.
        Chemopreventive agents: selenium.
        Pharmacol Ther. 1998; 79: 179-192
        • Rayman M.P.
        The importance of selenium to human health.
        Lancet. 2000; 356: 233-241
        • Clark L.C.
        • Combs Jr., G.F.
        • Turnbull B.W.
        • Clark L.C.
        • Combs Jr., G.F.
        • Turnbull B.W.
        • Slate E.H.
        • Chalker D.K.
        • Chow J.
        • et al.
        Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
        JAMA. 1996; 276: 1957-1963
        • Duffield-Lillico A.J.
        • Reid M.E.
        • Turnbull B.W.
        • Combs Jr., G.F.
        • Slate E.H.
        • Fischbach L.A.
        • et al.
        Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
        Cancer Epidemiol Biomarkers Prev. 2002; 11: 630-639
        • Lippman S.M.
        • Klein E.A.
        • Goodman P.J.
        • Lucia M.S.
        • Thompson I.M.
        • Ford L.G.
        • et al.
        Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT).
        JAMA. 2009; 301: 39-51
        • Bleys J.
        • Navas-Acien A.
        • Guallar E.
        Selenium and diabetes: more bad news for supplements.
        Ann Intern Med. 2007; 147: 271-272
        • Stapleton S.R.
        Selenium: an insulin-mimetic.
        Cell Mol Life Sci. 2000; 57: 1874-1879
        • Mueller A.S.
        • Pallauf J.
        Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice.
        J Nutr Biochem. 2006; 17: 548-560
        • Bleys J.
        • Navas-Acien A.
        • Guallar E.
        Serum selenium and diabetes in U.S. adults.
        Diabetes Care. 2007; 30: 829-834
        • Laclaustra M.
        • Navas-Acien A.
        • Stranges S.
        • Ordovas J.M.
        • Guallar E.
        Serum selenium concentrations and diabetes in US adults: national health and nutrition examination survey (NHANES 2003–2004).
        Environ Health Perspect. 2009; 117: 1409-1413
        • Stranges S.
        • Marshall J.R.
        • Natarajan R.
        • Donahue R.P.
        • Trevisan M.
        • Combs G.F.
        • et al.
        Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial.
        Ann Intern Med. 2007; 147: 217-223
        • Navarro-Alarcon M.
        • Lopez GdlSH
        • Perez-Valero V.
        • Lopez-Martinez C.
        Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus.
        Sci Total Environ. 1999; 228: 79-85
        • Kljai K.
        • Runje R.
        Selenium and glycogen levels in diabetic patients.
        Biol Trace Elem Res. 2001; 83: 223-229
        • Coudray C.
        • Roussel A.M.
        • Mainard F.
        • Arnaud J.
        • Favier A.
        Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study.
        J Am Coll Nutr. 1997; 16: 584-591
        • Akbaraly T.N.
        • Arnaud J.
        • Rayman M.P.
        • Hininger-Favier I.
        • Roussel A.M.
        • Berr C.
        • et al.
        Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective epidemiology of vascular ageing study.
        Nutr Metab. 2010; 7: 21
        • Czernichow S.
        • Couthouis A.
        • Bertrais S.
        • Vergnaud A.C.
        • Dauchet L.
        • Galan P.
        • et al.
        Antioxidant supplementation does not affect fasting plasma glucose in the supplementation with antioxidant vitamins and minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations.
        Am J Clin Nutr. 2006; 84: 395-399
        • Rajpathak S.
        • Rimm E.
        • Morris J.S.
        • Hu F.
        Toenail selenium and cardiovascular disease in men with diabetes.
        J Am Coll Nutr. 2005; 24: 250-256
        • Bleys J.
        • Navas-Acien A.
        • Stranges S.
        • Menke A.
        • Miller 3rd, E.R.
        • Guallar E.
        Serum selenium and serum lipids in US adults.
        Am J Clin Nutr. 2008; 88: 416-423
        • Laclaustra M.
        • Stranges S.
        • Navas-Acien A.
        • Ordovas J.M.
        • Guallar E.
        Serum selenium and plasma lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004.
        Atherosclerosis. 2010; 210: 643-648
        • Stranges S.
        • Laclaustra M.
        • Ji C.
        • Cappuccio F.P.
        • Navas-Acien A.
        • Ordovas J.M.
        • et al.
        Higher selenium status is associated with adverse blood lipid profile in British adults.
        J Nutr. 2010; 140: 81-87
        • Rayman M.P.
        Dietary selenium: time to act.
        BMJ. 1997; 314: 387-388
        • Yang K.C.
        • Lee L.T.
        • Lee Y.S.
        • Huang H.Y.
        • Chen C.Y.
        • Huang K.C.
        Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study.
        Nutr Metab. 2010; 7: 38
        • Ringstad J.
        • Jacobsen B.K.
        • Thomassen Y.
        The Tromso heart study: relationships between the concentration of selenium in serum and risk factors for coronary heart disease.
        J Trace Elem Electrolytes Health Dis. 1987; 1: 27-31
        • Jossa F.
        • Trevisan M.
        • Krogh V.
        • Farinaro E.
        • Giumetti D.
        • Fusco G.
        • et al.
        Serum selenium and coronary heart disease risk factors in southern Italian men.
        Atherosclerosis. 1991; 87: 129-134
        • Suadicani P.
        • Hein H.O.
        • Gyntelberg F.
        Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males.
        Atherosclerosis. 1992; 96: 33-42
        • Gamez C.
        • Ruiz-Lopez D.
        • Artacho R.
        • Navarro M.
        • Puerta A.
        • Lopez C.
        Serum selenium in institutionalized elderly subjects and relation to other nutritional markers.
        Clin Chem. 1997; 43: 693-694
        • Hercberg S.
        • Bertrais S.
        • Czernichow S.
        • Noisette N.
        • Galan P.
        • Jaouen A.
        • et al.
        Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX study.
        Lipids. 2005; 40: 335-342
        • Zhang L.
        • Gail M.H.
        • Wang Y.Q.
        • Brown L.M.
        • Pan K.F.
        • Ma J.L.
        • et al.
        A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.
        Am J Clin Nutr. 2006; 84: 912-919
        • Luoma P.V.
        • Sotaniemi E.A.
        • Korpela H.
        • Kumpulainen J.
        Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol–effect of selenium supplementation.
        Res Commun Chem Pathol Pharmacol. 1984; 46: 469-472
        • Yu S.Y.
        • Mao B.L.
        • Xiao P.
        • Yu W.P.
        • Wang Y.L.
        • Huang C.Z.
        • et al.
        Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study.
        Biol Trace Elem Res. 1990; 24: 105-108
      1. Rayman MP, Stranges S, Griffin B, Wong MCY, Guallar E. Effect of supplementation with high-selenium yeast on plasma lipids: a randomized, controlled trial. Proc Nutr Soc, in press.

        • Nawrot T.S.
        • Staessen J.A.
        • Roels H.A.
        • Den Hond E.
        • Thijs L.
        • Fagard R.H.
        • et al.
        Blood pressure and blood selenium: a cross-sectional and longitudinal population study.
        Eur Heart J. 2007; 28: 628-633
        • Salonen J.T.
        • Salonen R.
        • Seppanen K.
        • Kantola M.
        • Parviainen M.
        • Alfthan G.
        • et al.
        Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men.
        Atherosclerosis. 1988; 70: 155-160
        • Virtamo J.
        • Valkeila E.
        • Alfthan G.
        • Punsar S.
        • Huttunen J.K.
        • Karvonen M.J.
        Serum selenium and the risk of coronary heart-disease and stroke.
        Am J Epidemiol. 1985; 122: 276-282
        • Laclaustra M.
        • Navas-Acien A.
        • Stranges S.
        • Ordovas J.M.
        • Guallar E.
        Serum selenium levels and hypertension in the US population.
        Circ Cardiovasc Qual Outcomes. 2009; 2: 369-376
        • Brown B.G.
        • Zhao X.Q.
        • Chait A.
        • Fisher L.D.
        • Cheung M.C.
        • Morse J.S.
        • et al.
        Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
        N Engl J Med. 2001; 345: 1583-1592
        • Mark S.D.
        • Wang W.
        • Fraumeni Jr., J.F.
        • Li J.Y.
        • Taylor P.R.
        • Wang G.Q.
        • et al.
        Do nutritional supplements lower the risk of stroke or hypertension?.
        Epidemiology. 1998; 9: 9-15
        • Salonen J.T.
        • Alfthan G.
        • Huttunen J.K.
        • Pikkarainen J.
        • Puska P.
        Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study.
        Lancet. 1982; 2: 175-179
        • Wei W.Q.
        • Abnet C.C.
        • Qiao Y.L.
        • Dawsey S.M.
        • Dong Z.W.
        • Sun X.D.
        • et al.
        Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death.
        Am J Clin Nutr. 2004; 79: 80-85
        • Flores-Mateo G.
        • Navas-Acien A.
        • Pastor-Barriuso R.
        • Guallar E.
        Selenium and coronary heart disease: a meta-analysis.
        Am J Clin Nutr. 2006; 84: 762-773
        • Bleys J.
        • Navas-Acien A.
        • Guallar E.
        Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults.
        Arch Intern Med. 2008; 168: 404-410
        • Bleys J.
        • Navas-Acien A.
        • Laclaustra M.
        • Pastor-Barriuso R.
        • Menke A.
        • Ordovas J.M.
        • et al.
        Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey (NHANES 2003–2004).
        Am J Epidemiol. 2009; 169: 996-1003
        • Korpela H.
        • Kumpulainen J.
        • Jussila E.
        • Kemilä S.
        • Kääriäinen M.
        • Kääriäinen T.
        • et al.
        Effect of selenium supplementation after acute myocardial infarction.
        Res Commun Chem Pathol Pharmacol. 1989; 65: 249-252
        • Kuklinski B.
        • Weissenbacher E.
        • Fahnrich A.
        Coenzyme Q10 and antioxidants in acute myocardial infarction.
        Mol Aspects Med. 1994; 15: S143-S147
        • You W.C.
        • Chang Y.S.
        • Heinrich J.
        • Ma J.L.
        • Liu W.D.
        • Zhang L.
        • et al.
        An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
        Eur J Cancer Prev. 2001; 10: 257-263
        • Hercberg S.
        • Galan P.
        • Preziosi P.
        • Bertrais S.
        • Mennen L.
        • Malvy D.
        • et al.
        The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
        Arch Intern Med. 2004; 164: 2335-2342
        • Stranges S.
        • Marshall J.R.
        • Trevisan M.
        • Natarajan R.
        • Donahue R.P.
        • Combs G.F.
        • et al.
        Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial.
        Am J Epidemiol. 2006; 163: 694-699
        • Blankenberg S.
        • Rupprecht H.J.
        • Bickel C.
        • Torzewski M.
        • Hafner G.
        • Tiret L.
        • et al.
        Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.
        N Engl J Med. 2003; 349: 1605-1613
        • Duffield A.J.
        • Thomson C.D.
        • Hill K.E.
        • Williams S.
        An estimation of selenium requirements for New Zealanders.
        Am J Clin Nutr. 1999; 70: 896-903
        • Whanger P.
        • Vendeland S.
        • Park Y.C.
        • Xia Y.
        Metabolism of sub-toxic levels of selenium in animals and humans.
        Ann Clin Lab Sci. 1996; 26: 99-113
        • Vinceti M.
        • Wei E.T.
        • Malagoli C.
        • Bergomi M.
        • Vivoli G.
        Adverse health effects of selenium in humans.
        Rev Environ Health. 2001; 16: 233-251
        • Jablonska E.
        • Gromadzinska J.
        • Sobala W.
        • Reszka E.
        • Wasowicz W.
        Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism.
        Eur J Nutr. 2008; 47: 47-54
        • Alanne M.
        • Kristiansson K.
        • Auro K.
        • Silander K.
        • Kuulasmaa K.
        • Peltonen L.
        • et al.
        Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts.
        Hum Genet. 2007; 122: 355-365
        • Fürnsinn C.
        • Englisch R.
        • Ebner K.
        • Nowotny P.
        • Vogl C.
        • Waldhäusl W.
        Insulin-like vs. non-insulin-like stimulation of glucose metabolism by vanadium, tungsten, and selenium compounds in rat muscle.
        Life Sci. 1996; 59: 1989-2000
        • Sheng X.Q.
        • Huang K.X.
        • Xu H.B.
        Influence of alloxan-induced diabetes and selenite treatment on blood glucose and glutathione levels in mice.
        J Trace Elem Med Biol. 2005; 18: 261-267
        • Satyanarayana S.
        • Sekhar J.R.
        • Kumar K.E.
        • Shannika L.B.
        • Rajanna B.
        • Rajanna S.
        Influence of selenium (antioxidant) on gliclazide induced hypoglycaemia/anti hyperglycaemia in normal/alloxan-induced diabetic rats.
        Mol Cell Biochem. 2006; 283: 123-127
        • McClung J.P.
        • Roneker C.A.
        • Mu W.
        • Lisk D.J.
        • Langlais P.
        • Liu F.
        • et al.
        Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase.
        Proc Natl Acad Sci U S A. 2004; 101: 8852-8857
        • Li X.
        • Chen H.
        • Epstein P.N.
        Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells.
        Diabetes. 2006; 55: 1592-1604
        • Wang X.D.
        • Vatamaniuk M.Z.
        • Wang S.K.
        • Roneker C.A.
        • Simmons R.A.
        • Lei X.G.
        Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice.
        Diabetologia. 2008; 51: 1515-1524
        • Chen X.
        • Scholl T.O.
        • Leskiw M.J.
        • Donaldson M.R.
        • Stein T.P.
        Association of glutathione peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy.
        J Clin Endocrinol Metab. 2003; 88: 5963-5968
        • Shen C.L.
        • Song W.
        • Pence B.C.
        Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes.
        Cancer Epidemiol Biomarkers Prev. 2001; 10: 385-390
        • Chen J.J.
        • Boylan L.M.
        • Wu C.K.
        • Spallholz J.E.
        Oxidation of glutathione and superoxide generation by inorganic and organic selenium compounds.
        Biofactors. 2007; 31: 55-66
        • Schiar V.P.
        • Dos Santos D.B.
        • Paixão M.W.
        • Nogueira C.W.
        • Rocha J.B.
        • Zeni G.
        Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: a possible involvement of reactive oxygen species.
        Chem Biol Interact. 2009; 177: 28-33
        • Roberts C.K.
        • Sindhu K.K.
        Oxidative stress and metabolic syndrome.
        Life Sci. 2009; 84: 705-712
        • Rayman M.P.
        • Infante H.G.
        • Sargent M.
        Food-chain selenium and human health: spotlight on speciation.
        Br J Nutr. 2008; 100: 238-253
        • Burk R.F.
        • Hill K.E.
        • Olson G.E.
        • Weeber E.J.
        • Motley A.K.
        • Winfrey V.P.
        • et al.
        Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed.
        J Neurosci. 2007; 27: 6207-6211
        • Valentine W.M.
        • Abel T.W.
        • Hill K.E.
        • Austin L.M.
        • Burk R.F.
        Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2.
        J Neuropathol Exp Neurol. 2008; 67: 68-77
        • Burk R.F.
        • Hill K.E.
        Selenoprotein P – expression, functions, and roles in mammals.
        Biochim Biophys Acta. 2009; 1790: 1441-1447
        • Olson G.E.
        • Winfrey V.P.
        • Hill K.E.
        • Burk R.F.
        Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells.
        J Biol Chem. 2008; 283: 6854-6860
        • Sengupta A.
        • Carlson B.A.
        • Hoffmann V.J.
        • Gladyshev V.N.
        • Hatfield D.L.
        Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism.
        Biochem Biophys Res Commun. 2008; 365: 446-452
        • Moosmann B.
        • Behl C.
        Selenoprotein synthesis and side-effects of statins.
        Lancet. 2004; 363: 892-894
        • Arnaud J.
        • Akbaraly T.N.
        • Hininger-Favier I.
        • Berr C.
        • Roussel A.M.
        Fibrates but not statins increase plasma selenium in dyslipidemic aged patients – the EVA study.
        J Trace Elem Med Biol. 2009; 23: 21-28
      2. Dietary reference values for food energy and nutrients for the UK: Committee on medical aspects of food policy, report on health and social subjects number 41.
        HM Stationery Office, London1991
        • Food and Nutrition Board, Institute of Medicine
        Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. A report of the panel on dietary antioxidants and related compounds, subcommittees on upper reference levels of nutrients and interpretation and uses of dietary reference intakes, and the standing committee on the scientific evaluation of dietary reference intakes.
        National Academy Press, Washington, DC2000
        • Vinceti M.
        • Maraldi T.
        • Bergomi M.
        • Malagoli C.
        Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry.
        Rev Environ Health. 2009; 24: 231-248
        • Millen A.E.
        • Dodd K.W.
        • Subar A.F.
        Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 national health interview survey results.
        J Am Diet Assoc. 2004; 104: 942-950
        • Broadley M.R.
        • White P.J.
        • Bryson R.J.
        • Meacham M.C.
        • Bowen H.C.
        • Johnson S.E.
        • et al.
        Biofortification of UK food crops with selenium.
        Proc Nutr Soc. 2006; 65: 169-181
        • Xia Y.
        • Hill K.E.
        • Byrne D.W.
        • Xu J.
        • Burk R.F.
        Effectiveness of selenium supplements in a low selenium area of China.
        Am J Clin Nutr. 2005; 81: 829-834
        • Burk R.F.
        • Norsworthy B.K.
        • Hill K.E.
        • Motley A.K.
        • Byrne D.W.
        Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial.
        Cancer Epidemiol Biomarkers Prev. 2006; 15: 804-810
        • Combs Jr., G.F.
        Selenium in global food systems.
        Br J Nutr. 2001; 85: 517-547
        • Rayman M.P.
        Food-chain selenium and human health: emphasis on intake.
        Br J Nutr. 2008; 100: 254-268
        • Mueller A.S.
        • Mueller K.
        • Wolf N.M.
        • Pallauf J.
        Selenium and diabetes: an enigma?.
        Free Radic Res. 2009; 43: 1029-1059
        • Gore F.
        • Fawell J.
        • Bartram J.
        Too much or too little? A review of the conundrum of selenium.
        J Water Health. 2010; 8: 405-416